Chronic Low Back Pain Clinical Trial
Official title:
An Investigation Into the Effectiveness of Treatment of Chronic Low Back Pain
RATIONALE: Exposure in vivo therapy aims to reduce pain-related fear - a key maintaining
factor of chronic low back pain- while increasing level of daily functioning, despite the
pain. This is done by exposing patients to their most feared activities/movements, while
behavioral experiments are performed that serve to correct catastrophic (erroneous) beliefs
about pain. Yet, performing exposure exercises might be very threatening for patients and
might encourage them to build in subtle safety-seeking behavior. Whether safety-seeking
behavior should be allowed or not during therapy is heavily debated. Whereas some argue that
it will only interfere with therapeutic progress because it prevents the disconfirming
experience exposure tries to offer, other argue that it will facilitate therapeutic progress
because it enhances one's sense of control, if used judiciously. So far
(clinical-)experimental studies have provided mixed evidence nor have they lead to any
clinical recommendation. Hence, in a replicated single-case experiment, we will compare
exposure therapy with versus exposure without safety-seeking behavior versus exposure only.
STUDY POPULATION: Participants are chronic low back pain patients seeking treatment, who
fulfill all inclusion and exclusion criteria and participate voluntarily.
INTERVENTION: All participants receive exposure therapy at the rehabilitation department of
the academic hospital in Maastricht, but with different recommendations for the use of
safety-seeking behavior.
We will assess: 1) daily measures of fear, pain intensity and self-reported achievement of
goals and 2) non-daily measures of pain disability, pain-related fear, pain catastrophizing,
pain solutions, need to control and safety-seeking behavior. To measure to the influence of
safety-seeking behavior on actual level of functioning, two behavioral performance tasks
will also be presented, ie. a bag carrying task and a personalized task.
BURDEN AND RISKS: There are no risks associated with participation to this study that are
not otherwise related to rehabilitation and movement in general and participation is
completely voluntary. Participants are requested to fill out questionnaires on a daily basis
at home (computerized if possible), as well as on different time points during the study and
at follow up and perform two behavioral performance tasks. This study could help to further
improve the beneficial long-term effects of exposure.
Status | Active, not recruiting |
Enrollment | 6 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Suffer from chronic low back pain not caused by serious spinal injury, for at least 3 to 6 months - Report a sufficient level of disability (this is in itself already a criterion to start treatment at the Rehabilitation department) and - Moderate to high levels of pain-related fear (TSK > 37 or at least 4 items with a score of 3 or >3) - Have a partner willing to participate Exclusion Criteria: - Specific medical disorder or cardiovascular disease preventing participation in physical exercise - Serious psychopathologic co-morbidity. This is checked during anamnesis in the intake session with the rehabilitation physician and during the screening (standard care, see session 1 and session 2). When psychopathologic co-morbidity is detected, patients cannot participate in the study and may not be suitable candidates for exposure therapy entirely. Any decision regarding treatment recommendation is made with the entire treatment team. Furthermore, the researcher performing the therapy has a Master's degree in Clinical Psychology, which adds to the treatment team's expertise on psychopathology. - Alcohol or drug abuse, i.e., at least one out of the four following criteria needs to be fulfilled: continued use despite social or interpersonal problems; repeated use resulting in failure to fulfill obligations at work, school, or home; repeated use resulting in physically hazardous situations; use resulting in legal problems (according to the Diagnostic Statistical Manual of Mental disorders, 4th ed.). This is assessed by the rehabilitation physician during the first session. - Illiteracy - Pregnancy - Involvement in litigation concerning the patient's ability to work or disability income - Non-Dutch speaking |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht medical care center, department of rehabilitation | Maastricht |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center | Katholieke Universiteit Leuven, Maastricht University |
Netherlands,
Vlaeyen JW, de Jong J, Geilen M, Heuts PH, van Breukelen G. Graded exposure in vivo in the treatment of pain-related fear: a replicated single-case experimental design in four patients with chronic low back pain. Behav Res Ther. 2001 Feb;39(2):151-66. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in pain-related fear level from baseline to end of treatment at 9 weeks and to follow-up at 20 weeks to 51 weeks | Three self-report measures are used: 1) daily measures of fear, 2) The Tampa Scale of Kinesiophobia (TSK): a questionnaire to o assess general level of fear of (re)injury due to movement, 2) The Photograph Series of Daily activities(PHODA) and the PHODA-Short electronic version (PHODA-SeV): a tool to assess the perceived harmfulness of specific daily activities. | baseline and 9 weeks , 20 weeks, and 51 weeks | No |
Secondary | Change in back pain-related disability from baseline to end of treatment at 9 weeks and to follow-up at 20 weeks and 51 weeks | Two behavioral tasks assessed at baseline and follow-up. Two types of self-report measure are used: 1) daily measures of perceived level of functioning and ability to achieve desired activities and goals 2) non-daily questionnaire of back pain specific disability | baseline, 9 weeks, 20, 51 weeks | No |
Secondary | Change in pain from baseline to end of treatment at 9 weeks and to follow up at 20 weeks and 51 weeks | Self-reported pain intensity, pain unpleasantness via daily measures | baseline, 9 weeks, 20 weeks and 51 weeks | No |
Secondary | Change in pain catastrophizing from baseline to end of treatment at 9 weeks and to follow up at 20 weeks and 51 weeks | Self-report: 1) daily measures of catastrophizing levels, 2) pain catastrophizing questionnaire, assessed at baseline and follow-up | baseline, 9 weeks, 20 weeks and 51 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |